This is new, Writer. Aubrey Jenkins reveals that CardieX/InHealth Medical Services has a clinical trial coming where "we’ve partnered with Kaiser and California State Long Beach to study the many effects of weight reduction in 500 patients.
"One of the things that we look at is the frequency of visits, so that we can better understand the move from high-touch care to a more technology-based program.
"In other words, as the patient moves through the program, at what point do you bring the high touch back in or at what point can you titrate them off of the high-touch care?
"There’s no literature out there that talks about frequency of visits and what it actually takes for long-term success."
Jenkins doesn't mention a target date for trial results.
When the results are in I sense CDX CEO Craig Cooper will be keen to make an announcement,
This is new, Writer. Aubrey Jenkins reveals that...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
-0.010(6.67%) |
Mkt cap ! $17.65M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 17.5¢ | 13.5¢ | $186.0K | 1.196M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 66974 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 14000 | 1 |
View Market Depth
| Last trade - 13.57pm 15/11/2024 (20 minute delay) ? |
| CDX (ASX) Chart |
